Synthesis, structural characterisation and solution chemistry of ruthenium(III) triazole-thiadiazine complexes

Delferro, M., Marchiò, L., Tegoni, M., Tardito, S. , Franchi-Gazzola, R. and Lanfranchi, M. (2009) Synthesis, structural characterisation and solution chemistry of ruthenium(III) triazole-thiadiazine complexes. Dalton Transactions(19), pp. 3766-3773. (doi: 10.1039/B823271G) (PMID:19417942)

Full text not currently available from Enlighten.

Abstract

Two ruthenium(III) complexes structurally similar to the anticancer compound NAMI were prepared: Na[RuCl4(DMSO)(L1)] (1) and Na[RuCl4(DMSO)(L2)] (2), where L1 and L2 are differently functionalised triazole-thiadiazine ligands. To facilitate the crystallisation of the complex anions, Na+ was substituted with the [bis(triphenylphosphoranylidene)ammonium] cation (PPN+), allowing the X-ray characterisation of PPN[RuCl4(DMSO)(L1)]·2H2O (1a·2H2O) and PPN[RuCl4(DMSO)(L2)]·3H2O (2a·3H2O), respectively. The two compounds undergo stepwise hydrolytic processes, as assessed by means of UV-vis and 1H NMR spectroscopy. The first hydrolytic step consists of the replacement of a chloride anion with a water molecule, with a half-life of 50 min (1) and 110 min (2), while the subsequent hydrolytic steps are more complicated to describe since more than one product is generated at the same time. The redox potential of the Ru(III)/Ru(II) couple (0.31 V for 1 and 0.28 V for 2) suggests that these complexes can be reduced in the intracellular environment, in agreement with the “activation by reduction” mechanism proposed for NAMI and NAMI-A. 1 and 2 were tested on a human cancer cell line derived from a fibrosarcoma (HT1080), and on non-cancerous primary human fibroblasts (HF), where they showed a modest inhibitory effect.

Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Tardito, Dr Saverio
Authors: Delferro, M., Marchiò, L., Tegoni, M., Tardito, S., Franchi-Gazzola, R., and Lanfranchi, M.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cancer Sciences
Journal Name:Dalton Transactions
Publisher:Royal Society of Chemistry
ISSN:1477-9226
ISSN (Online):1477-9234
Published Online:20 March 2009

University Staff: Request a correction | Enlighten Editors: Update this record